Contract Development and Manufacturing Organization(CDMO)
Your Partner in Molecular Diagnostics

Transforming ideas into reliable products with scalable quality.

Advanced Solutions for Molecular Diagnostics. Where assay and integrated instrument design come together to create market ready solutions.

Why Credo

Credo Diagnostics Biomedical has delivered innovative and reliable molecular diagnostic platforms for over
a decade. With our experience in assay development, cartridge engineering, enzymology, nucleic acid extraction, and system integration, we support partners worldwide in bringing high quality diagnostic solutions to market faster and with confidence.

10+ Years in Molecular Experience​​

More than a decade of commercial molecular diagnostic development with products deployed in mutiple countries.

End to End Technical Capability​

Complete end to end capabilities in assay design, stabilization technologies, workflow engineering manufacturing and quality systems.​

Highly Customized Development​

Tailored reagent and instrument development aligned with your target application, workflow, and UI requirements.​​​​

Certified Manufacturing Quality

ISO 13485 and MDSAP certified manufacturing ensuring consistent, compliant, and globally reliable production.

What We Offer

From Single Services to Full CDMO Programs - Flexible by Design

1. Assay Development

2. Sample Processing

3. Enzyme Development and Supply

4. Instrument and System Development

From Concept to Completion

Flexible Solution at Every Stage of Development

1

STEP 1

Project requirement discussion

2

STEP 2

Feasibility study and technical recommendations

3

STEP 3

Prototype or pilot batch

4

STEP 4

Verification and optimization

5

STEP 5

Scale up and deliver

6

STEP 6

Long term technical support

Designed for Your Needs

From Startups to Established Diagnostic Manufacture

Let’s Build Your Diagnostic Solution Together

Whether you need a complete diagnostic product or specific technical expertise, our team is ready to support your next innovation.